Non-Executive Director

Jan Groen is currently the CEO of Novigenix SA in Switzerland and holds a PhD in medical microbiology from the Erasmus University in Rotterdam. He has many years of management experience (VP R&D, COO, CEO) in the life science industry with a focus on emerging technologies, product development and commercialization. Jan has raised over $150…

Non-Executive Director

Todd holds a BSc in Bioengineering and Pre-Medicine from The Catholic University of America (Washington, USA). Todd is a highly successful international healthcare executive with more than 30+ years’ experience in life sciences companies. He has worked as global sales director for companies in molecular diagnostics, laboratory services, and medical devices such as Interleukin Genetics,…

Non-Executive Director

Jorge holds a Master’s Degree in Industrial Production from ICADE (Madrid, Spain) and a MBA from Instituto de Empresa (Madrid, Spain). He joined the family business Laboratorios Landerlan in 1980, responsible for blood derivatives production. In 1988, he became a Director of Landerland Diagnostico, a position he held until 1999. From 1999 to 2017, he…

Co-Founder and Executive Director

Juan J. Díaz-Mochón holds a PhD in Pharmacy. He has enjoyed a distinguished academic career in Spain, Italy, and in the UK. Juan is a Professor at the Faculty of Pharmacy, University of Granada (Spain). Juan has more than 60 peer-reviewed manuscripts and 8 patents. He has established a number of start-ups in Spain, UK…

HI2

Co-Founder and Executive Director

Hugh Ilyine is an entrepreneur with more than 25 years of international experience in biotechnology and multinational corporations. He has covered start-ups through to multi-country fund raising and stock listings on the UK AIM and the Australian Stock Exchange. Hugh brings a wealth of experience in industrial product marketing and negotiation of multi-million dollar technology…

Non-Executive Chairman

David Whitcombe has more than 10 years of academic research and 15 years in industrial R&D. David has produced a number of publications and patents including the Scorpions technology that formed the basis of his start-up business DxS Ltd in 2000. He was Head of Technology Development at AstraZeneca Diagnostics for four years leading a…